Veritas Investment Partners (Uk) Ltd. has filed its 13F form on October 18, 2024 for Q3 2024 where it was disclosed a total value porftolio of $5.24 Billion distributed in 65 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Unitedhealth Group Inc with a value of $417M, Thermo Fisher Scientific Inc. with a value of $342M, Mastercard Inc with a value of $341M, Microsoft Corp with a value of $332M, and Marsh & Mclennan Companies, Inc. with a value of $320M.

Examining the 13F form we can see an increase of $214M in the current position value, from $5.03B to 5.24B.

Veritas Investment Partners (Uk) Ltd. is based out at London, X0

Below you can find more details about Veritas Investment Partners (Uk) Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $5.24 Billion
Technology: $2.14 Billion
Healthcare: $1.19 Billion
Financial Services: $674 Million
Consumer Cyclical: $527 Million
Industrials: $502 Million
Communication Services: $197 Million
Consumer Defensive: $2.42 Million
Utilities: $725,000
Other: $553,000

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 65
  • Current Value $5.24 Billion
  • Prior Value $5.03 Billion
  • Filing
  • Period Q3 2024
  • Filing Date October 18, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 9 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 25 stocks
Track This Portfolio

Track Veritas Investment Partners (Uk) Ltd. Portfolio

Follow Veritas Investment Partners (Uk) Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritas Investment Partners (Uk) Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Veritas Investment Partners (Uk) Ltd. with notifications on news.